IMNM
Immunome, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +24.9% · posisi baru bersih 0.0% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 82 | +1 | 68.26M | $1.45B | +7 | −7 |
| Q1 2026 | 85 | +8 | 69.87M | $1.52B | +12 | −4 |
| Q4 2025 | 77 | -1 | 71.18M | $1.53B | n/a | −1 |
| Q3 2025 | 17 | 0 | 44.21M | $517.66M | +1 | −1 |
| Q2 2025 | 14 | -2 | 33.29M | $309.62M | n/a | −2 |
| Q1 2025 | 13 | 0 | 18.78M | $126.42M | +1 | −1 |
| Q4 2024 | 13 | +3 | 9.20M | $97.76M | +3 | n/a |
| Q3 2024 | 9 | -2 | 5.86M | $85.63M | n/a | −2 |
| Q2 2024 | 11 | n/a | 5.95M | $72.02M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 13.06M | +111.7% | $152.89M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 2 | BlackRock ✦ (pasif) | 5.82M | +0.9% | $68.18M | 0.0% | ▲ Add | 2 | SEC ↗ ×10 |
| 3 | The Vanguard Group ✦ (pasif) | 4.89M | +8.2% | $57.30M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | Point72 Asset Management ✦ | 4.82M | +3.0% | $56.49M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 3.74M | +25.5% | $43.83M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | PRIMECAP Management ✦ | 3.02M | -0.1% | $35.34M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (pasif) | 2.80M | +11.2% | $32.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasif) | 1.89M | +1.8% | $22.19M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 1.83M | n/a | $21.47M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 10 | Citadel Advisors ✦ | 841.14K | Baru | $9.85M | 0.0% | New | 1 | SEC ↗ ×2 |
| 11 | Marshall Wace ✦ | 692.18K | -46.7% | $8.11M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | Wellington Management ✦ | 254.07K | +19.9% | $2.98M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 13 | Goldman Sachs Group ✦ | 208.95K | n/a | $2.45M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 14 | Renaissance Technologies ✦ | 202.30K | +103.6% | $2.37M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | JPMorgan Chase ✦ | 65.21K | n/a | $763,562 | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 16 | Millennium Management ✦ | 41.88K | -63.1% | $490,462 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 10.20K | 0.0% | $119,442 | 0.0% | Held | 3 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Citadel Advisors | $9.85M | 0.0% |
Telah keluar
| Two Sigma Investments | $247,882 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 35.50K saham, $776 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 13.20K lbr · $334,224
Director · 11.05K lbr · $301,058
Director · 62.29K lbr · $1.63M
Director · 10.12K lbr · $263,959
Director · 15.25K lbr · $397,363
Director · 20.84K lbr · $543,090
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi